<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the present study, we examined the neuroprotective effect of gamma-glutamylethylamide (theanine) on the ischemic brain damage in a middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> model in mice </plain></SENT>
<SENT sid="1" pm="."><plain>Theanine was injected i.p </plain></SENT>
<SENT sid="2" pm="."><plain>3 h after the occlusion or immediately before and 3 h after the occlusion </plain></SENT>
<SENT sid="3" pm="."><plain>Theanine (1 mg/kg) significantly decreased the size of the cerebral <z:mpath ids='MPATH_124'>infarcts</z:mpath> 1 day after the occlusion </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast, theanine did not affect the cerebral blood flow, brain temperature and physiological variables (pH, pCO(2), pO(2) and hematocrit) in this model </plain></SENT>
<SENT sid="5" pm="."><plain>These results suggest that theanine directly provides neuroprotection against focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and may be clinically useful for preventing <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
</text></document>